National Emergency Medical Services Memorial Extension Act This bill reauthorizes the National Emergency Medical Services Memorial Foundation to establish in Washington, DC, a monument to commemorate the commitment and service represented by emergency medical services. This authorization expires seven years after enactment of the bill.
HR 1869 creates a new DOJ task force within the Criminal Division to investigate and prosecute international trade crimes, such as customs evasion, smuggling, and trade-based money laundering. It requires the DOJ to hire specialized prosecutors, coordinate with agencies like U.S. Customs and Border Protection, and focus on specific violations covered under statutes like 18 U.S.C. §§ 541-546 and 21 U.S.C. § 331. The bill authorizes $20 million in funding for fiscal year 2026 (with 80% dedicated to criminal prosecutions), mandates annual reports to Congress on enforcement activities, and requires the DOJ to develop multi-agency partnerships to address these crimes. This directly affects federal prosecutors, border enforcement agencies, and industries impacted by trade violations.
This bill extends the funding authorization for the Accelerating Access to Critical Therapies for ALS Act from 2026 to 2031, ensuring continued financial support for research into treatments for amyotrophic lateral sclerosis. It requires the Food and Drug Administration to review clinical trial data more rigorously by assessing patient enrollment numbers and requesting interim results from drug manufacturers before renewing research grants. Additionally, the legislation clarifies that clinical trials in phase 3 include combined phase 2/3 studies and planned trials that have not yet started enrolling participants. The bill also mandates the FDA to publish a report within a year of enactment detailing its progress on rare neurodegenerative disease action plans and how it coordinates with broader disease communities. Finally, it adjusts the timeline for a Government Accountability Office report to cover a five-year period instead of four.
National Plan for Epilepsy Act This bill requires the Department of Health and Human Services (HHS) to establish a national plan, form an advisory council, and take other actions to address epilepsy. The requirements sunset on December 31, 2035. Specifically, the bill requires HHS to carry out a National Plan for Epilepsy to prevent, diagnose, treat, and cure epilepsy. In carrying out the plan, HHS must implement activities such as coordinating research and services across all federal agencies and soliciting public comments. Also, HHS must establish an Advisory Council on Epilepsy Research, Care, and Services. The advisory council must report to HHS and Congress every two years with an evaluation of federally funded efforts. Additionally, HHS must annually report to Congress with recommended actions based on its assessments of the nation’s progress on epilepsy.
This resolution designates the week of August 22 through August 30, 2026, as "National Park Week." It directly affects the public by encouraging responsible visits and support for the National Park System, which includes parks, battlefields, and historical sites located across the United States and its territories. The measure serves as a formal declaration to highlight the parks' role in recreation, education, and economic activity without altering any laws or funding.
This resolution designates July 30, 2026, as "National Whistleblower Appreciation Day" to honor individuals who report misconduct, fraud, or abuse within the government. It requires federal agencies to inform employees, contractors, and the public about the legal protections available for reporting wrongdoing and to acknowledge the contributions whistleblowers make to saving taxpayer money. The bill does not create new laws or penalties but serves as a commemorative measure to encourage ethical reporting and recognize the role of whistleblowers in maintaining an ethical government.
This concurrent resolution directs the President to withdraw United States Armed Forces from any hostilities against Iran. It specifically invokes the War Powers Resolution, mandating this removal unless Congress formally declares war or provides specific authorization for military force against Iran. The bill clarifies that it does not prevent the U.S. from acting in self-defense, maintaining a defensive troop presence in the region, or continuing intelligence activities related to threats from Iran.
This bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.
This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
HR 4123, the FIT Procurement Act, modernizes federal information and communications technology (ICT) procurement by requiring new training for federal acquisition staff and streamlining processes to boost small business participation. The bill mandates a cross-functional ICT training program covering cloud computing, AI, cybersecurity, and commercial tech adoption, with learning objectives focused on outcome-based contracting and reducing waste. It increases simplified acquisition thresholds ($250,000 to $500,000) and micro-purchase limits ($10,000 to $25,000) to reduce administrative barriers. The Act also directs the Comptroller General to assess small business participation in federal tech contracts and requires agencies to eliminate unnecessary procedural hurdles for small businesses. These changes directly affect federal procurement staff, small businesses competing for contracts, and executive agencies managing ICT acquisitions.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
HR 2306 extends the Adams Memorial Commission's authority until 2032 and authorizes $50 million in federal funds for the memorial, requiring a 1:1 non-federal match and limiting administrative costs to 4% of federal funds. It updates location rules to allow the memorial within a designated area mapped by the Commission. The bill primarily affects the Adams Memorial Commission and entities contributing to the memorial's funding. It makes no new policy changes but adjusts procedural timelines and funding requirements for an existing commemorative project.
